Current Concepts in Drug‐Induced Mitochondrial Toxicity
暂无分享,去创建一个
[1] L. Marroquin,et al. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. , 2008, Toxicology and applied pharmacology.
[2] G. Labbe,et al. Drug‐induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies , 2008, Fundamental & clinical pharmacology.
[3] S. Carr,et al. A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.
[4] K. Wallace. Mitochondrial off targets of drug therapy. , 2008, Trends in pharmacological sciences.
[5] Tak W. Mak,et al. Cytochrome c: functions beyond respiration , 2008, Nature Reviews Molecular Cell Biology.
[6] J. Xu,et al. In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[7] Fernando J. Pineda,et al. Mitochondrial fission and fusion dynamics: the long and short of it , 2008, Cell Death and Differentiation.
[8] R. Ferrante,et al. Mitochondrial nuclear receptors and transcription factors: Who's minding the cell? , 2008, Journal of neuroscience research.
[9] D. Green,et al. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? , 2008, Trends in cell biology.
[10] Katie Chan,et al. Drug‐Associated Mitochondrial Toxicity , 2008 .
[11] L. Wojtczak,et al. Basic Mitochondrial Physiology in Cell Viability and Death , 2008 .
[12] E. McKee. Assessing Mitochondrial Protein Synthesis in Drug Toxicity Screening , 2008 .
[13] I. Scheffler. Basic Molecular Biology of Mitochondrial Replication , 2008 .
[14] A. D. Ronde,et al. Mitochondrial Toxicity of Antiviral Drugs: A Challenge to Accurate Diagnosis , 2008 .
[15] R. Capaldi,et al. Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. , 2007, Toxicology and applied pharmacology.
[16] Yvonne Will,et al. The significance of mitochondrial toxicity testing in drug development. , 2007, Drug discovery today.
[17] P. Bottoni,et al. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. , 2007, American journal of physiology. Cell physiology.
[18] U. Boelsterli,et al. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[19] I. Scheffler. Mitochondrial Electron Transfer and Oxidative Phosphorylation , 2007 .
[20] Yvonne Will,et al. Strategies to reduce late-stage drug attrition due to mitochondrial toxicity , 2007, Expert review of molecular diagnostics.
[21] E. Böttger,et al. Visions & Reflections ( Minireview ) Antimicrobial agents targeting the ribosome : the issue of selectivity and toxicity lessons to be learned , 2007 .
[22] B. Antonsson,et al. A tale of two mitochondrial channels, MAC and PTP, in apoptosis , 2007, Apoptosis.
[23] C. Chinopoulos,et al. Bioenergetics and the formation of mitochondrial reactive oxygen species. , 2006, Trends in pharmacological sciences.
[24] S. Krähenbühl,et al. Toxicity of statins on rat skeletal muscle mitochondria , 2006, Cellular and Molecular Life Sciences CMLS.
[25] D. Pessayre,et al. The Anti-Inflammatory Drug, Nimesulide (4-Nitro-2-phenoxymethane-sulfoanilide), Uncouples Mitochondria and Induces Mitochondrial Permeability Transition in Human Hepatoma Cells: Protection by Albumin , 2006, Journal of Pharmacology and Experimental Therapeutics.
[26] A. T. Bentley,et al. Inhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones , 2006, Antimicrobial Agents and Chemotherapy.
[27] Y. Masubuchi,et al. Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones. , 2006, Toxicology.
[28] G. Kroemer,et al. Apoptosis-inducing factor: vital and lethal. , 2006, Trends in cell biology.
[29] Katie Chan,et al. Drug-induced mitochondrial toxicity , 2005, Expert opinion on drug metabolism & toxicology.
[30] U. Boelsterli,et al. Mitochondrial permeability transition as a source of superoxide anion induced by the nitroaromatic drug nimesulide in vitro. , 2005, Free radical biology & medicine.
[31] D. Green,et al. Apoptotic Pathways: Ten Minutes to Dead , 2005, Cell.
[32] Michael Roden,et al. Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I , 2004, Journal of Pharmacology and Experimental Therapeutics.
[33] N. Kaplowitz,et al. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. , 2004, Biochemical pharmacology.
[34] J. Turrens,et al. Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.
[35] H. Kusuhara,et al. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. , 2003, Molecular pharmacology.
[36] Bradford W. Gibson,et al. Characterization of the human heart mitochondrial proteome , 2003, Nature Biotechnology.
[37] K. Penttilä,et al. Effects of entacapone and tolcapone on mitochondrial membrane potential. , 2002, European journal of pharmacology.
[38] L. Schwartz,et al. Effects of troglitazone on HepG2 viability and mitochondrial function. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[39] Y. Masubuchi,et al. Role of mitochondrial permeability transition in diclofenac‐induced hepatocyte injury in rats , 2002, Hepatology.
[40] K. Wallace,et al. The effect of peroxisome proliferators on mitochondrial bioenergetics. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[41] H. Möller,et al. Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics , 1997, Molecular and Cellular Biochemistry.
[42] G. Barlovatz-Meimon,et al. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells , 1997, Journal of the Neurological Sciences.
[43] J. Casida,et al. Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone. , 1990, Biochemical and biophysical research communications.
[44] M. Weiner,et al. Mechanism of action of agents which uncouple oxidative phosphorylation: direct correlation between proton-carrying and respiratory-releasing properties using rat liver mitochondria. , 1975, Biochimica et biophysica acta.
[45] A. Psarra,et al. Nuclear receptors and other nuclear transcription factors in mitochondria: regulatory molecules in a new environment. , 2008, Biochimica et biophysica acta.
[46] Lorenzo Galluzzi,et al. Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.
[47] U. Boelsterli. Disruption of Mitochondrial Function and Mitochondria-Mediated Toxicity , 2007 .
[48] K. Wallace,et al. Adriamycin-induced oxidative mitochondrial cardiotoxicity , 2006, Cell Biology and Toxicology.
[49] A. Starkov,et al. Mitochondrial targets of drug toxicity. , 2000, Annual review of pharmacology and toxicology.
[50] C. Liébecq,et al. The toxicity of fluoroacetate and the tricarboxylic acid cycle. 1949. , 1989, Biochimica et biophysica acta.